China Resources Medical Holdings Company Limited (1PH) — Cash Flow-to-Debt Ratio
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €270.22 Million could theoretically repay 0% of its total liabilities (€11.33 Billion) in one year. See free cash flow generation of China Resources Medical Holdings Company to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China Resources Medical Holdings Company Limited Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for China Resources Medical Holdings Company Limited across 9 annual periods. Also explore China Resources Medical Holdings Company equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for China Resources Medical Holdings Company Limited (2016–2024)
Year-by-year debt coverage analysis for China Resources Medical Holdings Company Limited. For market capitalisation and broader financial context, see China Resources Medical Holdings Company stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | €1.27 Billion | €5.82 Billion | ▲ +21.3% |
| 2023 | 0.18x | €1.20 Billion | €6.64 Billion | ▲ +17.9% |
| 2022 | 0.15x | €626.58 Million | €4.11 Billion | ▼ -22.2% |
| 2021 | 0.20x | €710.43 Million | €3.62 Billion | ▼ -20.1% |
| 2020 | 0.25x | €643.69 Million | €2.62 Billion | ▲ +16.2% |
| 2019 | 0.21x | €366.05 Million | €1.73 Billion | ▲ +1.7% |
| 2018 | 0.21x | €334.15 Million | €1.61 Billion | ▼ -40.7% |
| 2017 | 0.35x | €459.54 Million | €1.31 Billion | ▲ +70.6% |
| 2016 | 0.21x | €223.79 Million | €1.09 Billion | — |